Top 25 Clovis Oncology investors
The most complete profiles first. Showing 25 of 25.
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
paul klingensteinVerified
Venture Capital · United States
Series BSeries AHealth CareWearablesHospitalsWellnessPortfolio: Alibris, goBalto, Kit Check, Eledon Pharmaceuticals and 32 more
Verified email available
Clarissa BermanVerified
Venture Capital, Private Equity Firm · United States
Health CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Verified email available
Kent BerkleyVerified
Venture Capital, Private Equity Firm · United States
Health CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Verified email available
Patrick HeronVerified
Private Equity Firm · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Steve B.Verified
Venture Capital, Private Equity Firm · United States
Health CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Daniel Estes
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 71 more
Contact details available
Gordon Empey
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Alan Frazier
Private Equity Firm · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Contact details available
Anna H. Chen
Venture Capital, Private Equity Firm · United States
Health CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Contact details available
Ben Magnano
Private Equity Firm · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Contact details available
Brian Morfitt
Venture Capital, Private Equity Firm · United States
Health CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Michael Machak
Venture Capital, Private Equity Firm · United States
Health CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Contact details available
Nathan Every
Venture Capital, Private Equity Firm · United States
Health CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Contact details available
Philip Zaorski
Venture Capital, Private Equity Firm · United States
Health CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Shyamal Swami
Venture Capital, Private Equity Firm · United States
Health CareWellnessWomen FoundedFilmPortfolio: Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics and 68 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Clovis Oncology investors are on Angel Roster?
Angel Roster lists 25 Clovis Oncology investors. 9 of them (36%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (22), Private Equity Firms (18) and Advisor Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Clovis Oncology investors invest in?
Among those that list a stage, the most common are Series B (7), Seed (2) and Series A (1).
Where are Clovis Oncology investors based?
Most are based in the United States (20) and the United Kingdom (5).
Which companies have Clovis Oncology investors backed?
The most-backed portfolio companies among them are Vaxcyte (24), Phathom Pharmaceuticals (24), Portola Pharmaceuticals (24), Tobira Therapeutics (14) and Gritstone Oncology (14).
How do I contact Clovis Oncology investors?
Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.